French, David P. http://orcid.org/0000-0002-7663-7804
Astley, Susan
Brentnall, Adam R.
Cuzick, Jack
Dobrashian, Richard
Duffy, Stephen W.
Gorman, Louise S.
Harkness, Elaine F.
Harrison, Fiona
Harvie, Michelle
Howell, Anthony
Jerrison, Andrew
Machin, Matthew
Maxwell, Anthony J.
McWilliams, Lorna
Payne, Katherine
Qureshi, Nadeem
Ruane, Helen
Sampson, Sarah
Stavrinos, Paula
Thorpe, Emma
Ulph, Fiona
van Staa, Tjeerd
Woof, Victoria
Evans, D. Gareth
Funding for this research was provided by:
Programme Grants for Applied Research (RP-PG-1214-20016)
Manchester Biomedical Research Centre (IS-BRC-1215-20007)
Genesis Research Trust (GA15-003)
Prevent Breast Cancer (GA18-001)
Breast Cancer Now (2018RP005)
Article History
Received: 1 May 2020
Accepted: 9 June 2020
First Online: 18 June 2020
Ethics approval and consent to participate
: NHS ethical approval for the study described in the manuscript was granted by Harrow Research Ethics Committee (ref 18/LO/0649)/ IRAS project ID 239199. All participants in BC-Predict complete written consent (usually online). All data participants in the comparison (usual NHSBSP) condition will be elicited in aggregate form, so individual consent will not be obtained.
: Not applicable, as protocol paper.
: Prof Cuzick and Dr. Brentnall report receiving royalty payments through Cancer Research UK for commercial use of the Tyrer-Cuzick algorithm. All other authors report no competing interests.